Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Strategies for Discovering Novel Pancreatic Cancer Biomarkers
Journal of Proteomics
Biochemistry
Biophysics
Preclinical Evaluation of Exemestane as a Novel Chemotherapy for Gastric Cancer
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
Molecular Cancer Therapeutics
Cancer Research
Oncology
Pulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer
Cancer Research
Cancer Research
Oncology
Development of Novel Preclinical Models of Secondary Resistance to the Pi3kδ Inhibitor Idelalisib in Splenic Marginal Zone Lymphoma (Smzl)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Antitumor Activity of the Polo-Like Kinase Inhibitor, TAK-960, Against Preclinical Models of Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined With DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
EZH2 Inhibition Enhances the Efficacy of an EGFR Inhibitor in Suppressing Colon Cancer Cells
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Preclinical Activity of Selinexor, an Inhibitor of XPO1, in Sarcoma
Oncotarget
Oncology
Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance.
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
‹
2
3
4
5
6
7
8
›
